[Gout and myxedema].
作者信息
Ryckewaert A, Massé C, Jurmand S H, Caroit M, Durieu J, Guérin C, de Séze S
出版信息
Sem Hop. 1967 Nov 26;43(49):3059-62.
PMID:4298290
Abstract
摘要
相似文献
1
[Gout and myxedema].
Sem Hop. 1967 Nov 26;43(49):3059-62.
2
[Diagnostic value of hyperuricemia].[高尿酸血症的诊断价值]
Presse Med (1893). 1968 Dec 14;76(49):2319-22.
3
[Effect of benziodarone on hyperuricemia due to fasting].
Policlinico Med. 1972 May-Jun;79(3):151-64.
4
[Hyperuricemia and gout; treatment of an acute attack of gout].
Ned Tijdschr Geneeskd. 1983 Dec 3;127(49):2235-7.
5
[Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].[苯基丁氮酮衍生物塞托苯丁氮酮的促尿酸排泄作用]
Rev Rhum Mal Osteoartic. 1971 Jan;38(1):33-9.
6
[Current etiopathogenetic and therapeutic views concerning gout and hyperuremic syndromes].
Minerva Med. 1973 Jan 20;64(4):144-56.
7
Gout in women.女性痛风
Med Health R I. 2009 Nov;92(11):363-4, 368.
8
[Benziodarone in the basic treatment of gout].
Rev Rhum Mal Osteoartic. 1972 Jan;39(1):33-9.
9
[Changes in the serum concentration of uric acid under the effect of benzbromaronum].
Munch Med Wochenschr. 1969 Feb 28;111(9):491-5.
10
[Benziodarone in the treatment of primary hyperuricemias].[苯碘达隆治疗原发性高尿酸血症]
Minerva Med. 1968 Dec 12;59(99):5470-81.
引用本文的文献
1
The interpretation of the serum protein-bound iodine: A review.血清蛋白结合碘的解读：一篇综述。
J Clin Pathol. 1971 Apr;24(3):187-218. doi: 10.1136/jcp.24.3.187.
Zotero 插件